Page 2 - சிகிச்சை பொருட்கள் சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The new weapons in the war against COVID-19 Global virus treatments are evolving beyond vaccines as countries discover there are more ways than one to deal with the pandemic. Social distancing at a traffic junction on Orchard Road, Singapore.  Getty Updated Save Share Singapore/Jakarta | Vaccines are not the only option when it comes to fighting COVID-19. In Singapore on Thursday, the country’s Health Sciences Authority expedited the approval for GlaxoSmithKline’s new therapy. GSK’s sotrovimab is designed to stop mild or moderate COVID-19 from progressing to severe disease. In the US, regulators brought a trial of the new drug, developed by GSK with Vir Biotechnology, to an early close because the results were so good. There was an 85 per cent reduction in hospitalisation or death in those receiving sotrovimab compared with those taking a placebo.

United arab emiratesNew zealandJakarta rayaEmma connorssouth east asiaSanjoy dattaHealth sciences authorityEuropean medicines agencyAustralia therapeutic goods associationDrug administrationVir biotechnologyEuropean medicinesTherapeutic goods associationGreater chinaஒன்றுபட்டது அரபு அமீரகங்கள்புதியது ஜீலாந்துஜகார்த்தா ராய